Ronald C JR Renaud
CIK 1354434 · CEO & President · last filed 2026-06-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$332.5K
Companies
11
Total Filings
55
Lifetime Open-Market Net
-$34.19M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| UPB | Director | — | $6.10 | — | $0 | 3 | 2026-06-11 |
| KLRA | CEO & President | 38,094 | — | — | $0 | 2 | 2026-06-11 |
| Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | President & CEO | 244,309 | $44.96 | $10.98M | $2.01M | 4 | 2024-01-23 |
| ATRA | Director | 31,500 | $10.41 | $327.9K | $0 | 3 | 2022-06-27 |
| ImageneBio, Inc. (IKNA) Delisted | Director | — | $17.16 | — | $0 | 2 | 2022-06-13 |
| TBIO | Chief Executive Officer | 0 | $0.00 | $0 | -$36.25M | 9 | 2021-09-14 |
| CHIMERIX INC (CMRX) Delisted | Director | — | $8.54 | — | $0 | 6 | 2019-06-24 |
| AKBA | Director | 5,000 | $0.92 | $4.6K | $59.6K | 6 | 2018-06-15 |
| PTCT | Director | — | $75.14 | — | $0 | 3 | 2017-01-05 |
| IDENIX PHARMACEUTICALS INC (IDIX) Delisted | President & CEO | 89,990 | — | — | $0 | 14 | 2014-08-05 |
| KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Chief Financial Officer | 94,027 | — | — | $0 | 2 | 2007-02-16 |
Recent Filings · Page 3 of 6
55 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-04-30 | ATRA | Grant (A) | — | $0 | EDGAR |
| 2020-03-05 | TBIO | Grant (A) | — | $0 | EDGAR |
| 2019-06-24 | CHIMERIX INC (CMRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-03-12 | TBIO | Grant (A) | — | $0 | EDGAR |
| 2018-07-03 | TBIO | Conv (C) | +81,818 | $0 | EDGAR |
| 2018-06-21 | CHIMERIX INC (CMRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-06-15 | AKBA | Grant (A) | — | $0 | EDGAR |
| 2017-06-29 | CHIMERIX INC (CMRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-06-19 | AKBA | Grant (A) | — | $0 | EDGAR |
| 2017-01-05 | PTCT | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.